Add to ORKGCopeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney diseas
Background: In this study, we examined the relative usefulness of serum copeptin levels as a surroga...
Background: Plasma copeptin, a marker of vasopressin, is associated with renal function decline in t...
Background and objectives Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent...
The observational study by Boertin et al makes a valuable contribution to the research field of prev...
Background: Experimental studies indicate that arginine vasopressin (AVP) may have deleterious effec...
Background: Experimental studies indicate that arginine vasopressin (AVP) may have deleterious effec...
Background and objectives Experimental studies suggest a detrimental role for vasopressin in the pat...
Contains fulltext : 174130.pdf (publisher's version ) (Closed access)Background.: ...
Background and objectives Plasma copeptin, a marker of arginine vasopressin, is elevated in patients...
<b><i>Background/Aims:</i></b> In recent days, chronic kidney disease (CKD) is becoming an increasin...
Background: Our aim was to test if plasma copeptin, a stable surrogate marker of arginine vasopressi...
In the TEMPO 3:4 Trial, treatment with tolvaptan, a vasopressin V2 receptor antagonist, slowed the i...
nephropathy, with an esti-mated prevalence of 1:1000. The disease is characterized by the developmen...
Background: In this study, we examined the relative usefulness of serum copeptin levels as a surroga...
Background: Plasma copeptin, a marker of vasopressin, is associated with renal function decline in t...
Background and objectives Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent...
The observational study by Boertin et al makes a valuable contribution to the research field of prev...
Background: Experimental studies indicate that arginine vasopressin (AVP) may have deleterious effec...
Background: Experimental studies indicate that arginine vasopressin (AVP) may have deleterious effec...
Background and objectives Experimental studies suggest a detrimental role for vasopressin in the pat...
Contains fulltext : 174130.pdf (publisher's version ) (Closed access)Background.: ...
Background and objectives Plasma copeptin, a marker of arginine vasopressin, is elevated in patients...
<b><i>Background/Aims:</i></b> In recent days, chronic kidney disease (CKD) is becoming an increasin...
Background: Our aim was to test if plasma copeptin, a stable surrogate marker of arginine vasopressi...
In the TEMPO 3:4 Trial, treatment with tolvaptan, a vasopressin V2 receptor antagonist, slowed the i...
nephropathy, with an esti-mated prevalence of 1:1000. The disease is characterized by the developmen...
Background: In this study, we examined the relative usefulness of serum copeptin levels as a surroga...
Background: Plasma copeptin, a marker of vasopressin, is associated with renal function decline in t...
Background and objectives Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent...